Form4insider filings, from the source

SEC Form 5 · accession 0001426812-15-000001

HERON THERAPEUTICS, INC. /DE/ · HRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Dec 31, 2014
Accepted (ET)
Feb 12, 2015 · 2:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Heron Therapeutics Common StockApr 29, 2014S2,000$12.0638D79,238IPecuniary Interest
Heron Therapeutics Common StockMay 7, 2014S1,000$12.50D79,238IPecuniary Interest
Heron Therapeutics Common StockJun 24, 2014S1,000$13.1108D79,238IPecuniary Interest
Heron Therapeutics Common StockJul 2, 2014S4,000$12.5478D79,238IPecuniary Interest
Heron Therapeutics Common StockJul 24, 2014S1,000$9.10D79,238IPecuniary Interest
Heron Therapeutics Common StockJul 29, 2014S1,000$9.0015D79,238IPecuniary Interest
Heron Therapeutics Common StockJul 30, 2014S1,000$9.3155D79,238IPecuniary Interest
Heron Therapeutics Common StockJul 31, 2014S1,000$9.2848D79,238IPecuniary Interest
Heron Therapeutics Common StockSep 19, 2014S1,000$9.07D79,238IPecuniary Interest
Heron Therapeutics Common StockSep 29, 2014S2,000$8.7433D79,238IPecuniary Interest
Heron Therapeutics Common StockDec 19, 2014S1,000$9.33D79,238IPecuniary Interest
Heron Therapeutics Common Stockholding———79,238IPecuniary Interest

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Andrew R. Midler serves as (i) a managing member of Standard Pacific Capital Holdings LLC ("SPCH"), and (ii) the trustee of The Moses Trust (the "Trust"). Mr. Midler has voting and dispositive power over the shares reported herein that are beneficially owned by each of SPCH and the Trust, respectively. Mr. Midler disclaims beneficial ownership of all shares reported herein except to the extent of his pecuniary interests therein.